Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / 2021 - Page 4

Year: 2021

Tonix Pharmaceuticals announced publication of paper on antiviral SARS-CoV-2 inhibitor, TNX-3500, in JCI Insight
Biotechnology | COVID-19 | Infectious Disease | Life Science History

Tonix Pharmaceuticals announced publication of paper on antiviral SARS-CoV-2 inhibitor, TNX-3500, in JCI Insight

On Nov. 22, 2021, Tonix Pharmaceuticals announced the publication of ‘Sangivamycin is highly effective against SARS-CoV-2 in vitro…

Read More Tonix Pharmaceuticals announced publication of paper on antiviral SARS-CoV-2 inhibitor, TNX-3500, in JCI InsightContinue

Follow-up data from phase 3 trial of Pfizer-BioNTech COVID-19 vaccine supported safety and high efficacy in adolescents 12 through 15 years of age
COVID-19 | Life Science History | Vaccine

Follow-up data from phase 3 trial of Pfizer-BioNTech COVID-19 vaccine supported safety and high efficacy in adolescents 12 through 15 years of age

On Nov. 22, 2021, Pfizer announced topline results from a longer-term analysis of the safety and efficacy of…

Read More Follow-up data from phase 3 trial of Pfizer-BioNTech COVID-19 vaccine supported safety and high efficacy in adolescents 12 through 15 years of ageContinue

FDA authorized InBios COVID-19 over-the-counter antigen test
COVID-19 | FDA | Life Science History

FDA authorized InBios COVID-19 over-the-counter antigen test

On Nov. 22, 2021, the U.S. Food and Drug Administration authorized another over-the-counter (OTC) COVID-19 antigen test. The…

Read More FDA authorized InBios COVID-19 over-the-counter antigen testContinue

India completed national introduction of pneumococcal conjugate vaccine
Life Science History | Vaccine

India completed national introduction of pneumococcal conjugate vaccine

On Nov. 21, 2021, Gavi, the Vaccine Alliance, announced that India has completed the national introduction of pneumococcal…

Read More India completed national introduction of pneumococcal conjugate vaccineContinue

FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and older

On Nov. 19, 2021, the U.S. Food and Drug Administration (FDA) announced that it had extended the emergency…

Read More FDA announced FDA authorization of Moderna’s booster dose of COVID-19 vaccine in the U.S. for adults 18 years and olderContinue

Pfizer and BioNTech received expanded U.S. FDA EUA of COVID-19 vaccine booster to include individuals 18 and older
COVID-19 | FDA | Life Science History

Pfizer and BioNTech received expanded U.S. FDA EUA of COVID-19 vaccine booster to include individuals 18 and older

On Nov. 19, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) had expanded…

Read More Pfizer and BioNTech received expanded U.S. FDA EUA of COVID-19 vaccine booster to include individuals 18 and olderContinue

Pfizer provided U.S. Government with 10 million treatment courses of oral antiviral candidate to help combat COVID-19
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Pfizer provided U.S. Government with 10 million treatment courses of oral antiviral candidate to help combat COVID-19

On Nov. 18, 2021, Pfizer announced an agreement with the U.S. government to supply 10 million treatment courses…

Read More Pfizer provided U.S. Government with 10 million treatment courses of oral antiviral candidate to help combat COVID-19Continue

CureVac published in Nature preclinical data of second-generation COVID-19 candidate
Life Science History | Vaccine

CureVac published in Nature preclinical data of second-generation COVID-19 candidate

On Nov. 18, 2021, CureVac announced the online publication of the extended preclinical study of the second-generation vaccine…

Read More CureVac published in Nature preclinical data of second-generation COVID-19 candidateContinue

Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in the Philippines
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in the Philippines

On Nov. 17, 2021, Novavax and and Serum Institute of India announced that the Philippine Food and Drug…

Read More Novavax and Serum Institute of India received Emergency Use Authorization for COVID-19 vaccine in the PhilippinesContinue

Novavax confirmed European Medicines Agencyreview of COVID-19 vaccine filing for Conditional Marketing Authorization
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax confirmed European Medicines Agencyreview of COVID-19 vaccine filing for Conditional Marketing Authorization

On Nov. 17, 2021, Novavax announced that the European Medicines Agency (EMA) had begun its evaluation of an…

Read More Novavax confirmed European Medicines Agencyreview of COVID-19 vaccine filing for Conditional Marketing AuthorizationContinue

Zosano Pharma announced successful formulation of COVID-19 vaccine candidate on its microneedle patch system
Biotechnology | COVID-19 | FDA | Infectious Disease | Nanotechnology | Vaccine

Zosano Pharma announced successful formulation of COVID-19 vaccine candidate on its microneedle patch system

On Nov. 17, 2021, Zosano Pharma announced that the Philippine Food and Drug Administration had granted emergency use…

Read More Zosano Pharma announced successful formulation of COVID-19 vaccine candidate on its microneedle patch systemContinue

PNNL-led study delivered road map of lung development
Biotechnology | Diagnostics | Disease | Therapeutics

PNNL-led study delivered road map of lung development

On Nov. 17, 2021, Pacific Northwest National Laboratory (PNNL) announced researchers had compiled the most comprehensive road map…

Read More PNNL-led study delivered road map of lung developmentContinue

GSK and Vir Biotechnology announced U.S. government agreements to purchase sotrovimab, a COVID-19 treatment
Biotechnology | COVID-19 | FDA | Therapeutics | Vaccine

GSK and Vir Biotechnology announced U.S. government agreements to purchase sotrovimab, a COVID-19 treatment

On Nov. 17, 2021, GlaxoSmithKline and Vir Biotechnology announced U.S. government contracts totalling approximately $1 billion (USD) to…

Read More GSK and Vir Biotechnology announced U.S. government agreements to purchase sotrovimab, a COVID-19 treatmentContinue

Imported Monkeypox case reported in Maryland
CDC | Life Science History

Imported Monkeypox case reported in Maryland

On Nov. 17, 2021, scientists at the Centers for Disease Control and Prevention (CDC) announced they were collaborating…

Read More Imported Monkeypox case reported in MarylandContinue

Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidate
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidate

On Nov. 16, 2021, Pfizer announced it had submitted an Emergency Use Authorization (EUA) of its investigational oral…

Read More Pfizer submitted Emergency Use Authorization for novel COVID-19 oral antiviral candidateContinue

Pfizer and MPP announced agreement for COVID-19 oral antiviral treatment candidate to expand access in low- and middle-income countries
COVID-19 | Life Science History

Pfizer and MPP announced agreement for COVID-19 oral antiviral treatment candidate to expand access in low- and middle-income countries

On Nov. 16, 2021, Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working…

Read More Pfizer and MPP announced agreement for COVID-19 oral antiviral treatment candidate to expand access in low- and middle-income countriesContinue

EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries
Biotechnology | COVID-19 | Infectious Disease | Vaccine

EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countries

On Nov. 16, 2021, an agreement was announced that enabled the European Union and European Economic Area countries…

Read More EU to donate more than 70 million doses of Moderna COVID-19 vaccine to COVAX to fight COVID-19 pandemic in low income countriesContinue

Illumina and Genetic Alliance Launch $120 million globa initiative to increase equity and improve outcomes for families impacted by genetic disease
Genomics | Life Science History

Illumina and Genetic Alliance Launch $120 million globa initiative to increase equity and improve outcomes for families impacted by genetic disease

On Nov. 16, 2021, Illumina and Genetic Alliance announced the creation of the iHopeル Genetic Health program aimed…

Read More Illumina and Genetic Alliance Launch $120 million globa initiative to increase equity and improve outcomes for families impacted by genetic diseaseContinue

Oxford / AstraZeneca vaccine reached two billion dose milestone
Life Science History | Vaccine

Oxford / AstraZeneca vaccine reached two billion dose milestone

On Nov. 16, 2021, the University of Oxfordメs and AstraZeneca announced that two billion doses of the ChAdOx1…

Read More Oxford / AstraZeneca vaccine reached two billion dose milestoneContinue

Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine

Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373

On Nov. 15, 2021, Novavax and SK bioscience announced submission of a Biologics License Application (BLA) for Novavax’…

Read More Novavax announced submission of Biologics License Application in South Korea for approval of NVX-CoV2373Continue

Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and older

On Nov. 15, 2021, Moderna confirmed that Health Canada had authorized the use of a booster dose of…

Read More Health Canada authorized booster dose of Moderna’s COVID-19 vaccine in individuals 18 years of age and olderContinue

Long-term study of children with COVID-19 began
COVID-19 | Life Science History

Long-term study of children with COVID-19 began

On Nov. 15, 2021, a large, long-term study of the impacts of COVID-19 on children announced it had…

Read More Long-term study of children with COVID-19 beganContinue

Oxford vaccine reached two billion dose milestone
Biotechnology | COVID-19 | Life Science History | Vaccine

Oxford vaccine reached two billion dose milestone

On Nov. 15, 2021, AstraZeneca reported that 2 billion doses of the COVID-19 vaccine had been released for…

Read More Oxford vaccine reached two billion dose milestoneContinue

Calgary reinstates fluoridation in City’s water System
Chemical | Dentistry | Disease | Therapeutics

Calgary reinstates fluoridation in City’s water System

On Nov. 14, 2021, the Calgary city council voted to reinstate fluoridation in Calgary’s waters. The count was…

Read More Calgary reinstates fluoridation in City’s water SystemContinue

Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19
COVID-19 | Life Science History

Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19

On Nov. 12, 2021, Regeneron announced that the European Commission (EC) had approved the casirivimab and imdevimab antibody…

Read More Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19Continue

Innovation Pharmaceuticals conducted full data analysis of phase 2 brilacidin COVID-19 trial results to support inclusion in Government-sponsored trials
COVID-19 | Life Science History

Innovation Pharmaceuticals conducted full data analysis of phase 2 brilacidin COVID-19 trial results to support inclusion in Government-sponsored trials

On Nov. 12, 2021, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…

Read More Innovation Pharmaceuticals conducted full data analysis of phase 2 brilacidin COVID-19 trial results to support inclusion in Government-sponsored trialsContinue

Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19
Biotechnology | COVID-19 | Life Science History

Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19

On Nov. 12, 2021, GlaxoSmithKline and Vir Biotechnology announced headline data from the randomised, multi-centre, open-label COMET-TAIL Phase…

Read More Primary endpoint met in COMET-TAIL Phase III trial evaluating intramuscular administration of sotrovimab for early treatment of COVID-19Continue

Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies
Life Science History | Nanotechnology

Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic Intensifies

On Sept. 21, 2021, the Medicines Patent Pool (MPP) announced that it had signed a licence agreement with…

Read More Leading Generic Drug Makers Unite to Pledge Capacity for Developing and Delivering Affordable COVID-19 Interventions as Pandemic IntensifiesContinue

Lincoln Children’s Zoo announced the deaths of three snow leopards due to COVID-19
COVID-19 | Life Science History

Lincoln Children’s Zoo announced the deaths of three snow leopards due to COVID-19

On Nov. 12, 2021, Lincoln Children’s Zoo announced on Facebook that their three snow leopards: Ranney, Everest and…

Read More Lincoln Children’s Zoo announced the deaths of three snow leopards due to COVID-19Continue

Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in Ghana
COVID-19 | Life Science History | Vaccine

Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in Ghana

On Nov. 11, 2021, Zipline, Pfizer and BioNTech announced that Zipline had successfully completed the first long-range drone…

Read More Zipline, Pfizer and BioNTech paved way for automated, on-demand delivery of first mRNA COVID-19 vaccines in GhanaContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 6 … 40 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search